|
|
|
|
|
|
| From Sequence To Scale In Seven Months | Case Study | Future Fields | Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes. |
|
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Subpar customer service at CDMOs is no longer something sponsors tolerate; there’s enough competition where they can move on. The other side of the coin is how difficult sponsors sink to the bottom of CDMO priorities; providers also have options. Here's an analysis less about technical components of outsourcing, and more on mutual satisfactions from working together to fulfill contractual arrangements and missions. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| How To Prepare For Risk-Based Biological Reactivity Testing | White Paper | By Jillian Miller, Pace® Life Sciences | Biological reactivity testing is moving from material classification toward risk-based evaluation, where chemistry data, exposure, and application determine what evidence is enough for each material. |
|
|
|
| Bridging Discovery, Developability, And Commercial Reality | Article | By Daniel Weinbuch and Andreas Stelzl, Coriolis Pharma | Driven by metabolic and oncology successes, the expanding peptide therapeutics market faces critical challenges requiring early, customized drug product development, stability, and safety strategies. |
|
|
| Strategic Approaches On The Path To GMP Manufacture | Q&A | Avid Bioservices | Tech transfer is a critical opportunity to establish a strategy for process performance qualification, mitigate late-stage obstacles, and streamline the pathway to clinical and commercial production. |
|
|
|
|
|
|
|
|
| Webinar: Beyond Destination and Delivery: Designing a Distribution Testing Program | Can your pharmaceutical packaging withstand the journey to patients? From vibration and impact to temperature changes and handling, distribution hazards can compromise product quality and package integrity. Join this webinar to explore ASTM and ISTA testing, learn how to design distribution simulations, and discover how pre- and post-test evaluations assess packaging performance and support product protection throughout the supply chain. Click here to learn more. |
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|